State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA
Open Access
Abstract
Objectives This study aims to characterise oxycodone’s distribution and opioid-related overdoses in the USA by state from 2000 to 2021. Design This is an observational study. Setting More than 80 000 Americans died of an opioid overdose in 2021 as the USA continues to struggle with an opioid crisis. Prescription opioids play a substantial role, introducing patients to opioids and providing a supply of drugs that can be redirected to those seeking to misuse them. Methods The Drug Enforcement Administration annual summary reports from the Automation of Reports and Consolidated Orders System provided weights of oxycodone distributed per state by business type (pharmacies, hospitals and practitioners). Weights were converted to morphine milligram equivalents (MME) per capita and normalised for population. The Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research provided mortality data for heroin, other opioids, methadone, other synthetic narcotics and other/unspecified narcotics. Results There was a sharp 280.13% increase in total MME/person of oxycodone from 2000 to 2010, followed by a slower 54.34% decrease from 2010 to 2021. Florida (2007–2011), Delaware (2003–2020) and Tennessee (2012–2021) displayed consistent and substantial elevations in combined MME/person compared with other states. In the peak year (2010), there was a 15-fold difference between the highest and lowest states. MME/person from only pharmacies, which constituted >94% of the total, showed similar results. Hospitals in Alaska (2000–2001, 2008, 2010–2021), Colorado (2008–2021) and DC (2000–2011) distributed substantially more MME/person over many years compared with other states. Florida stood out in practitioner-distributed oxycodone, with an elevation of almost 15-fold the average state from 2006 to 2010. Opioid-related deaths increased +806% from 2000 to 2021, largely driven by heroin, other opioids and other synthetic narcotics. Conclusions Oxycodone distribution across the USA showed marked differences between states and business types over time. Investigation of opioid policies in states of interest may provide insight for future actions to mitigate opioid misuse.Keywords
This publication has 30 references indexed in Scilit:
- Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational studyeClinicalMedicine, 2021
- The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisisInternational Journal of Drug Policy, 2019
- Oxycodone’s Unparalleled Addictive Potential: Is it Time for a Moratorium?Current Pain and Headache Reports, 2019
- Trends in Medical Use of Opioids in the U.S., 2006–2016American Journal of Preventive Medicine, 2018
- Fentanyl in the US heroin supply: A rapidly changing risk environmentInternational Journal of Drug Policy, 2017
- Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysisDrug and Alcohol Dependence, 2016
- Effect of a “pill mill” law on opioid prescribing and utilization: The case of TexasDrug and Alcohol Dependence, 2016
- Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent Extended-Release Oxycodone and Withdrawal of PropoxypheneJAMA Internal Medicine, 2015
- The Changing Face of Heroin Use in the United StatesJAMA Psychiatry, 2014
- Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid usersThe Journal of Clinical Pharmacology, 2013